Coronary-Artery Bypass Surgery in Patients with Left Ventricular Dysfunction
New England Journal of Medicine2011Vol. 364(17), pp. 1607–1616
Citations Over TimeTop 1% of 2011 papers
Eric J. Velazquez, Kerry L. Lee, Marek Deja, Anil Jain, George Sopko, А. В. Марченко, Imtiaz S. Ali, Gerald Pohost, Siniša Gradinac, William T. Abraham, Michael Yii, Dorairaj Prabhakaran, Hanna Szwed, Paolo Ferrazzi, Mark C. Petrie, Christopher M. O’Connor, Pradit Panchavinnin, Lilin She, Robert O. Bonow, Gena Roush Rankin, Robert H. Jones, Jean-Lucien Rouleau
Abstract
In this randomized trial, there was no significant difference between medical therapy alone and medical therapy plus CABG with respect to the primary end point of death from any cause. Patients assigned to CABG, as compared with those assigned to medical therapy alone, had lower rates of death from cardiovascular causes and of death from any cause or hospitalization for cardiovascular causes. (Funded by the National Heart, Lung, and Blood Institute and Abbott Laboratories; STICH ClinicalTrials.gov number, NCT00023595.).
Related Papers
- → Coronary bypass surgery for unstable angina pectoris(1975)29 cited
- → PP-208 OPERATIVE RESULTS OF CORONARY ARTERY BYPASS SURGERY IN ELDERLY PATIENTS(2012)
- → Vein graft vs. native coronary artery as the optimal target of percutaneous coronary intervention in patients with previous coronary artery bypass graft surgery(2013)
- [Myocardial ischemia caused by anomaly at the origin of the left coronary artery].(1990)
- → 888 Prevention of postoperative atrial fibrillation after coronary artery bypass surgery by N-3 fatty acids(2005)